Creative Medical Technology Holdings, Inc. (CELZ) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Creative Medical Technology Holdings, Inc. (CELZ) closed at USD 0.77 on 2026-10-14, a change of -86.2 % over the past year, with a market capitalization of USD 6.21M.

Creative Medical Technology Holdings, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Creative Medical Technology Holdings, Inc. key figures

Previous close

USD 0.77 (2026-10-14)

1-year change

-86.2 %

Market cap

USD 6.21M

Enterprise value

USD -3.41M

P/E ratio (trailing)

-0.40

P/E ratio (forward)

-0.93

EPS (trailing)

-2.07

EPS (forward)

-0.88

PEG ratio

n/a

Price to book

0.61

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.14

Employees

4

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Creative Medical Technology Holdings, Inc.

Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness. It develops AlloStem (CELZ-201-DDT), a allogenic human perinatal tissue derived cell program, ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, which is phase 2, for the treatment of type 1 diabetes; AlloStemSpine (CELZ 201 ADAPT), which is phase 2, for the treatment of chronic lower back pain; Alova, a platform to treat infertility as a result of premature ovarian failure; StemSpine, a regenerative stem cell procedure to treat degenerative disc disease; OvaStem, a stem cell therapy for premature ovarian failure; CaverStem for erectile dysfunction treatment; and FemCelz for female sexual function treatment. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Creative Medical Technology Holdings, Inc. and compare it with other stocks.